{"i":{"17":{"name":"1 Low dose Canakinumab","spans":[{"i":"-1","f":"20","txt":"Low dose Canakinumab "},{"i":"4684","f":"4687","txt":"low"}]},"19":{"name":"2 Intermediate dose Canakinumab","spans":[{"i":"-1","f":"29","txt":"Intermediate dose Canakinumab "},{"i":"4720","f":"4732","txt":"intermediate"}]},"21":{"name":"3 Medium dose Canakinumab","spans":[{"i":"-1","f":"23","txt":"Medium dose Canakinumab "},{"i":"4799","f":"4805","txt":"medium"}]},"23":{"name":"4 High dose Canakinumab","spans":[{"i":"-1","f":"21","txt":"High dose Canakinumab "},{"i":"4883","f":"4887","txt":"high"},{"i":"5705","f":"5709","txt":"high"}]},"32":{"name":"5 placebo","spans":[{"i":"4966","f":"4973","txt":"placebo"},{"i":"5553","f":"5560","txt":"placebo"},{"i":"5676","f":"5683","txt":"placebo"},{"i":"5754","f":"5761","txt":"placebo"},{"i":"6019","f":"6026","txt":"placebo"},{"i":"-1","f":"-1","txt":"Placebo"},{"i":"-1","f":"-1","txt":"Placebo"},{"i":"-1","f":"-1","txt":"Placebo"},{"i":"-1","f":"-1","txt":"Placebo"}]}},"o":{"39":{"name":"1 adverse events","spans":[{"i":"4999","f":"5013","txt":"adverse events"},{"i":"5015","f":"5018","txt":"AEs"},{"i":"5078","f":"5081","txt":"AEs"},{"i":"5441","f":"5444","txt":"AEs"}]},"50":{"name":"2 serious AEs","spans":[{"i":"5021","f":"5032","txt":"serious AEs"},{"i":"5034","f":"5038","txt":"SAEs"},{"i":"5588","f":"5592","txt":"SAEs"}]},"53":{"name":"3 deaths","spans":[{"i":"5070","f":"5076","txt":"deaths"},{"i":"5851","f":"5856","txt":"death"}]},"55":{"name":"4 discontinuations due to AEs","spans":[{"i":"5041","f":"5068","txt":"discontinuations due to AEs"},{"i":"5789","f":"5822","txt":"discontinued treatment due to AEs"}]},"57":{"name":"5 laboratory abnormalities","spans":[{"i":"5161","f":"5185","txt":"laboratory abnormalities"}]},"59":{"name":"6 at least one AE","spans":[{"i":"5499","f":"5514","txt":"at least one AE"},{"i":"-1","f":"-1","txt":"At least one adverse event"},{"i":"-1","f":"-1","txt":"At least one adverse event"},{"i":"-1","f":"-1","txt":"At least one adverse event"},{"i":"-1","f":"-1","txt":"At least one adverse event"}]},"64":{"name":"7 rate of infection","spans":[{"i":"5950","f":"5967","txt":"rate of infection"},{"i":"-1","f":"-1","txt":"Infections "},{"i":"-1","f":"-1","txt":"Infections "},{"i":"-1","f":"-1","txt":"Infections "},{"i":"-1","f":"-1","txt":"Infections "}]},"70":{"name":"8 decreases in WBC, neutrophils and platelet counts","spans":[{"i":"6072","f":"6121","txt":"decreases in WBC, neutrophils and platelet counts"}]},"72":{"name":"9 increases in SGPT, SGOT and bilirubin","spans":[{"i":"6142","f":"6179","txt":"increases in SGPT, SGOT and bilirubin"}]}}}